NCT02102178 Occupational Therapy Modulates the Pain in Cancer Patient Under Palliative Care Status COMPLETED Phase PHASE2
NCT02095925 Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism Status COMPLETED Phase N/A
NCT02090530 Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing Status RECRUITING Phase N/A
NCT02085603 SarCaBon: A Randomised Phase II Trial of Saracatinib Versus Placebo for Cancer-induced Bone Pain Status COMPLETED Phase PHASE2
NCT02084355 Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain Status UNKNOWN Phase PHASE3
NCT02083354 Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma Status COMPLETED Phase PHASE2
NCT02082977 A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma Status TERMINATED Phase PHASE1
NCT02082665 Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam Status COMPLETED Phase PHASE1
NCT02078089 Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain Status TERMINATED Phase PHASE1
NCT02077621 Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer Status WITHDRAWN Phase PHASE2
NCT02076997 Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate Status COMPLETED Phase NA
NCT02072902 Diabetes, Glucose Control, Glucose Lowering Medications, and Cancer Risk: A 10-year Population-based Historical Cohort Status COMPLETED Phase N/A
NCT02072733 Suitability of an Organization With an Onco-geriatric Team to a Whole Region (Region Midt) of Denmark Status COMPLETED Phase NA
NCT02070328 Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up Status RECRUITING Phase N/A